Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Hui Fan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 3, 2020
[Intelligent and lean manufacturing for Chinese medicine:theory and its applications]Yi-Yu Cheng, Bo-Li Zhang, Tong-Hua Fang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 23, 2017
[Development and application of component-based Chinese medicine theory]Jun-Hua Zhang, Guan-Wei Fan, Han Zhang, et al.
Biomed Research International|February 25, 2021
Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell LineCun-Qing Kong, Xing-Cai Chen, Guan-Hua Qiu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|June 5, 2020
[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology]Yi Wang, Xiang Li, Jun-Hua Zhang, et al.
Aging|July 14, 2023
Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinomaHong-Sheng Lin, Wen-Peng Pang, Hao Yuan, et al.
Trials|January 5, 2024
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trialLi-Xin Pan, Yi-Yang Wang, Zhong-Hai Li, et al.
Pathology, Research and Practice|May 18, 2023
Clinicopathological value of hematopoietic cell kinase overexpression in laryngeal squamous cell carcinoma tissuesShuang Xia, Jian-Di Li, Shi-Bai Yan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|July 21, 2025
[Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions]Li Liu, Lei Zhang, Wei-An Yuan, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|April 3, 2020
[Intelligent and lean manufacturing for Chinese medicine:theory and its applications]Yi-Yu Cheng, Bo-Li Zhang, Tong-Hua Fang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 23, 2017
[Development and application of component-based Chinese medicine theory]Jun-Hua Zhang, Guan-Wei Fan, Han Zhang, et al.
Biomed Research International|February 25, 2021
Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell LineCun-Qing Kong, Xing-Cai Chen, Guan-Hua Qiu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|June 5, 2020
[Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology]Yi Wang, Xiang Li, Jun-Hua Zhang, et al.
Aging|July 14, 2023
Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinomaHong-Sheng Lin, Wen-Peng Pang, Hao Yuan, et al.
Trials|January 5, 2024
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trialLi-Xin Pan, Yi-Yang Wang, Zhong-Hai Li, et al.
Pathology, Research and Practice|May 18, 2023
Clinicopathological value of hematopoietic cell kinase overexpression in laryngeal squamous cell carcinoma tissuesShuang Xia, Jian-Di Li, Shi-Bai Yan, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|July 21, 2025
[Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions]Li Liu, Lei Zhang, Wei-An Yuan, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Pageof 7